World News: 21:15 GMT Monday 29th December 2014. [Repros Therapeutics Inc. via Globe Newswire via SPi World News]
THE WOODLANDS Texas Dec 29 2014 GLOBE NEWSWIRE -- Repros Therapeutics IncNasdaqRPRX today updated the regulatory status for its drug Androxal. Androxal is an oral therapy for the treatment of low testosterone due to secondary hypogonadism . Repr...
Globe Newswire: 21:15 GMT Monday 29th December 2014
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.